Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. (2012)

First Author: Moons KG
Attributed to:  MRC Clinical Trials Unit as the London Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/heartjnl-2011-301246

PubMed Identifier: 22397945

Publication URI: http://europepmc.org/abstract/MED/22397945

Type: Journal Article/Review

Volume: 98

Parent Publication: Heart (British Cardiac Society)

Issue: 9

ISSN: 1355-6037